Psilocybin (Magic Mushrooms) | National Institute on Drug Abuse
2024年1月24日 · Psilocybin is a chemical in certain types of mushrooms that can change a person's sense of reality and cause distorted perceptions. Learn how psilocybin works in the brain, what are its potential uses and risks, and how it differs from other psychedelics.
Law enforcement seizures of psilocybin mushrooms rose …
2024年2月6日 · A NIDA-funded study found that law enforcement seized more than 800 kg of psilocybin mushrooms in 2022, compared to 226 kg in 2017. Psilocybin is not approved by FDA and may have adverse effects, despite growing interest in its medical potential.
Psychedelic and Dissociative Drugs | National Institute on Drug …
2024年8月29日 · Learn about the effects, risks, and potential medical uses of psychedelic and dissociative drugs, such as psilocybin, MDMA, and ketamine. Find out how NIDA supports and conducts research on these substances and their interactions with the brain and body.
Psychedelic and Dissociative Drugs as Medicines
2024年1月24日 · NIDA supports and conducts research to investigate the health effects and potential medical uses of psychedelic and dissociative drugs, such as ketamine and psilocybin. Learn about the current FDA-approved drugs, the ongoing studies, the side effects, and the challenges of this field.
Commonly Used Drugs Charts | National Institute on Drug Abuse
2023年9月19日 · Learn about the effects, risks, and treatment options for various drugs that can alter a person’s thinking and judgment, and lead to health problems and addiction. Find information on alcohol, cannabis, cocaine, fentanyl, hallucinogens, and more.
What do drug tests really tell us? | National Institute on Drug Abuse
2023年10月27日 · Urine drug tests can be affected by false positives, environmental exposures, and drug metabolism. Learn how to avoid common pitfalls and get expert help from NIDA's staff clinician.
La psilocibina (setas u hongos mágicos) - National Institute on …
2024年1月24日 · La psilocibina es una sustancia química presente en algunos hongos que puede alterar la percepción y el estado de ánimo. El NIDA apoya la investigación de la psilocibina como un posible tratamiento para algunos trastornos mentales, pero también advierte de sus riesgos y efectos secundarios.
Faster approach for starting extended-release naltrexone to treat ...
2024年5月8日 · A clinical trial shows that starting people with opioid use disorder on extended-release, injectable naltrexone (XR-naltrexone) within five to seven days is more effective than the standard treatment method of starting within 10-15 days. The study also explores the challenges and benefits of this rapid procedure and the factors that affect treatment choice and retention.
NIDA.NIH.GOV | National Institute on Drug Abuse (NIDA)
NIDA is a federal agency that supports scientific research on drug use and addiction for 50 years. It provides information on prevention, treatment, harm reduction, stigma, and various substances and topics related to addiction science.
Emerging Drug Trends | National Institute on Drug Abuse (NIDA)
2024年6月17日 · Learn about emerging drugs, which are substances that have appeared or become more popular in the drug market in recent years. Find out their effects, health risks, and how NIDA supports research and surveillance on them.